Jdp Therapeutics Inc
USPTO Trademark & Patent Filings
Trademark applications and grants for Jdp Therapeutics Inc. Jdp Therapeutics Inc has 2 trademark applications. The latest application filed is for "URTIZIR"
- Company Aliases
- JDP Therapeutics Inc.
- JDP Therapeutics, Inc.
- JDP THERAPEUTICS, INC. - Lansdale PA
- JDP THERAPEUTICS, INC. - Landsale PA
Trademarks Patents
| Patent Application | Date |
|---|---|
| NON-SEDATING ANTIHISTAMINE INJECTION FORMULATIONS AND METHODS OF USE THEREOF 20130303546 - 13/940675 Du; Jie | 2013-11-14 |
| NON-SEDATING ANTIHISTAMINE INJECTION FORMULATIONS AND METHODS OF USE THEREOF 20130296829 - 13/940747 Du; Jie | 2013-11-07 |
| NON-SEDATING ANTIHISTAMINE INJECTION FORMULATIONS AND METHODS OF USE THEREOF 20120289489 - 13/559954 Du; Jie | 2012-11-15 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"URTIZIR" 87793615 |
URTIZIR 2018-02-12 |
"CETZIR" 87477398 |
CETZIR 2017-06-06 |
| SEC | 0001453347 | JDP THERAPEUTICS INC of PENNSYLVANIA |
| SEC | 0001488520 | JDP Therapeutics, Inc. of PENNSYLVANIA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 